|
PAPERS, ABSTRACTS,
CASE REPORTS,
LECTURE SLIDES
BY DR. BOB
|
All
articles, case reports, and slides from lectures are available in Adobe Acrobat
(PDF) format.
|
|
PAPERS
BY DR. BOB
|
New!
 Testosterone Replacement in Prostate Cancer Survivors with Hypogonadal Symptoms
(British Journal of Urology International,
EarlyView 11/2009, also accepted for print publication) -
coauthored with Tanya Dorff, Steven Tucker, James Symanowski and Nicholas Vogelzang
Dr. Bob's (Not So) Secret Recipe for Treating Metastatic, Advanced Or Recurrent Prostate Cancer
(11/2008)
Taxotere Plus Avastin: Antiangiogenic Proof of Principle (4/2008)
AntiangiogenicCocktail (AAC) (8/2008), formerly "LEUKINE
(GM-CSF) and REVLIMID,
the Second
Generation THALIDOMIDE Product" (updated 2/4/2008; originally written 09/2006)
Hormone
Refractory Prostate Cancer
(08/2004)
Treatment
of
Localized Prostate Cancer With Intermittent Triple Androgen Blockade:
Preliminary Results in 110 Consecutive Patients (2001)
Hormone Blockade as the Sole Treatment of Clinical Stages T1-T3 Prostate Cancer: Experience
in 100 Patients (2000 ASCO Annual Meeting abstract)
Low-Dose Single Agent Weekly Docetaxel (Taxotere) is Effective and Well Tolerated in Elderly Men with
Prostate Cancer (2001 ASCO Annual Meeting abstract)
- co-authored with M. Scholz, B. Guess, F. Barrios, & S. Strum
Intermittent Hormone Blockade for Localized Prostate Cancer (2001 ASCO Annual Meeting abstract)
- co-authored with S. Tucker
Five-year Follow-up of Intermittent Triple Androgen Blockade (TAB) for Clinically Localized
Prostate Cancer (PC): Prognostic Features and Preliminary Patterns of Failure
(2002 ASCO Annual Meeting abstract) - co-authored with S. Tucker
At What PSA Level Should Cycle Two of Hormone Blockade (HB) Commence in Men who Refuse Local
Treatment for Prostate Cancer (CaP) and are Treated with Intermittent Androgen Blockade (IAB)?
(2002 ASCO Annual Meeting abstract) - co-authored with S. Tucker
Low and Intermediate Risk Early Prostate Cancer (PC) Managed with Triple Androgen Blockade (TAB) (2003 ASCO Annual Meeting abstract) - co-authored with S. Tucker
Primary Triple Androgen Blockade (TAB) Followed by Finasteride Maintenance (FM) for Clinically
Localized Prostate Cancer (CL-PC): Long Term Follow-up and Quality of Life (QOL)
(2005 ASCO Prostate Cancer Symposium abstract) - co-authored with S. Tucker & J.N. Roundy
Primary Intermittent Chemo-Hormonal Therapy (CHT) for High Risk Locally Advanced (LAPC) or
Metastatic Prostate Cancer (MPC): Preliminary Results and Quality of Life (QOL)
(2005 ASCO Annual Meeting abstract) - co-authored with S. Tucker
Triple
Hormone
Blockade® Update: The Demise of the (Fool's) Gold Standard; The
Rise of the
"Platinum and Diamond Standard”; Peer Recognition
from the
Multidisciplinary Prostate Cancer
Conference, Orlando, Florida,
February 2005, and the First International Conference on IAB, London,
England, March 2005 (last updated 6/12/2008; originally written 02/2006)
New!
High-Dose Testosterone & Prostate Cancer : Wait until you read this update, September 1, 2009
(9/1/2009)
Also see:
"High-Dose
Testosterone
Replacement Therapy and Prostate Cancer"
"TRT Case Reports: High
Dose Testosterone Replacement Therapy (TRT) and Prostate Cancer (CaP)"
TRT
Case Reports:
High-Dose Testosterone Replacement Therapy (TRT) and Prostate Cancer
(CaP)
(updated 05/2009)
Also see:
"High-Dose Testosterone & Prostate Cancer : Wait until you read this update, September 1, 2009"
"High-Dose Testosterone
Replacement Therapy and Prostate Cancer "
High-Dose
Testosterone
Replacement Therapy and Prostate Cancer (11/2006),
Also see:
"High-Dose Testosterone & Prostate Cancer : Wait until you read this update, September 1, 2009"
"TRT Case Reports: High
Dose Testosterone Replacement Therapy (TRT) and Prostate Cancer (CaP)"
Proscar
Greetings On
Father's Day: 2008 Update(last
updated 6/25/08; originally written 06/1997)
I Am
The Only One You Are
Afraid To Believe (01/1999)
Hormone
Blockade; Continuous,
Intermittent, or ? formerly, "Dr. Bob's Approach," (03/06)
Potpourri of Prostate Pearls and Insights
(2007)
Statin
Drugs and Advanced
Risk of Prostate Cancer (01/2007)
Testosterone
Levels And Prostate
Cancer -- The Higher, The Better? (01/2003)
High-Dose
Testosterone Replacement
Therapy (06/2004)
Testosterone
ASCO Abstract (Phase I trial of exogenous testosterone (T) for the
treatment of castrate
metastatic prostate cancer (PC) –
Morris MJ et. al. (6/2004)),
Discussion by Robert L.
Leibowitz, MD 05/2004
The
Emperor's New Clothes or
"The Platinum And Diamond Standard" (04/2004),
Intermittent
Androgen Blockade
(Formerly "The Future Is Now!!" - Part II) (04/2004),
Prostate
"Pearls" (04/2004)
The
Will Rogers Phenomenon
(04/2004)
Early
Hormonal Therapy
Works Ridiculously Well (10/2003)
Celebrex,
and Anti-Cancer Activity (02/2007)
"PCAAC"
Prostate Cancer
Antiangiogenic Cocktail (09/2002)
"The
Facts, Doc, Just The
Facts" (04/2004)
Dawning
Of The Age Of
Angiogenesis (04/2004)
The
Capitulation Of
Radiation Therapy Has Begun (04/2004)
Angiostatin
And Why Local
Therapy Fails To Cure So Many Men (Formerly "The Transitional Zone Era")
(04/2004)
Hormone
Blockade Versus Radical
Local Therapies - And The Winner Is.... (11/2002)
Soy
and Prostate Cancer
(10/2007)
Bisphosphonates
and
Osteonecrosis of the Maxilla and/or Mandible (Jaw Bones)
(10/2005)
Aredia
Monotherapy to Control
Metastatic, Hormone Refractory Prostate Cancer for more than Six Years
(11/2006)
The
Risk of Thrombosis
(Blood Clots) with the use of Thalidomide and/or Revlimid (02/2007)
Interferon
and Anti-angiogenesis
(6/2007)
Celebrex,
a Cox-2 Inhibtor: Off Label Use for Treating Prostate and Other Cancers (12/2006)
December
2001
National Cancer
Institute Article (Treatment Options) (01/2002)
Dr.
Bob's
Recommended Vitamin List (10/2005)
New!
Shingles; Vaccine and Post Shingles Pain (04/2009)
|
